TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Former GM Exec as Chief Commercial Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the hiring of John Schwegman as its chief commercial officer (“CCO”) for Mullen’s line of commercial vehicles. Prior to joining Mullen, Schwegman spent 35 years of his career at General Motors (“GM”), holding various executive-level roles and leading global teams across four continents. At GM, he oversaw the growth of commercial product lines, repositioned core brands, developed Chevrolet’s core electric vehicle prioritization, relaunched GM’s previously retired medium-duty commercial fleet business and more. “John has tremendous experience in commercial automotive sales, and this makes him a highly strategic addition to Mullen,” said David Michery, CEO and chairman of Mullen Automotive. “We are very excited to have John on board; he will play a central role as CCO in the product planning and business development of our commercial vehicle division.”

To view the full news release, visit https://ibn.fm/p4kfg

About Mullen Automotive Inc.

Mullen is a Southern California-based automotive company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the United States. With an end-to-end ecosystem that supports owners from test driving to financing and servicing through a unique hybrid dealership model, customers are supported through every aspect of EV ownership. The Mullen FIVE, the company’s first electric crossover, is slated for delivery in 2024 and features an award-winning design and its patented PERSONA technology that utilizes facial recognition to personalize the driving experience for every individual. To learn more about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Vision in Action: Building the Grid of Tomorrow

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a…

4 days ago

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201,…

4 days ago

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Secures Military Contract Extension for Iridium PTT Services

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced that its subsidiary, Global Telesat Communications…

6 days ago

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Secures EV Van Sale to Global Expert Shipping

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced the sale of its all-electric Mullen…

7 days ago

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Halts Some U.S. Product Plans in China Over Tariff Escalation

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced it will pause select initiatives within…

7 days ago

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Appoints Oncology Expert Dr. Guy Travis Clifton as Chief Medical Officer

Calidi Biotherapeutics (NYSE American: CLDI) has named Dr. Guy Travis Clifton as Chief Medical Officer,…

2 weeks ago